Richard Goodwin
0000-0001-5699-8488
AstraZeneca R&D Cambridge
9 papers found
Refreshing results…
Morphological and molecular preservation through universal preparation of fresh-frozen tissue samples for multimodal imaging workflows
Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer
Inside Back Cover: Mass Spectrometry Detection and Imaging of a Non‐Covalent Protein–Drug Complex in Tissue from Orally Dosed Rats (Angew. Chem. Int. Ed. 36/2022)
Innenrücktitelbild: Mass Spectrometry Detection and Imaging of a Non‐Covalent Protein–Drug Complex in Tissue from Orally Dosed Rats (Angew. Chem. 36/2022)
Mass Spectrometry Detection and Imaging of a Non‐Covalent Protein–Drug Complex in Tissue from Orally Dosed Rats
Spatial visualization of comprehensive brain neurotransmitter systems and neuroactive substances by selective in situ chemical derivatization mass spectrometry imaging
Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung
Missing publications? Search for publications with a matching author name.